Summary
Definition
History and exam
Key diagnostic factors
- presença de fatores de risco
- tosse
- dispneia
- hemoptise
- dor torácica
- perda de peso
Other diagnostic factors
- idade entre 65 e 74 anos
- sexo masculino
- fadiga
- anormalidades observadas no exame pulmonar
- rouquidão
- confusão
- alterações da personalidade
- náuseas e vômitos
- cefaleia
- disfagia
- dor óssea e/ou fraturas
- convulsões
- adenopatia cervical ou supraclavicular
- edema facial
- veias dilatadas no pescoço ou na parede torácica/abdominal
- baqueteamento digital
- osteoartropatia hipertrófica
Risk factors
- tabagismo
- exposição ambiental ao tabaco
- exposição ao gás radônio
- exposição ao asbesto
Diagnostic investigations
1st investigations to order
- radiografia torácica
- TC do tórax, do fígado e das glândulas adrenais
Investigations to consider
- broncoscopia
- biópsia
- toracocentese
- toracoscopia
- ressonância nuclear magnética (RNM) ou TC cranioencefálica
- mediastinoscopia
- tomografia por emissão de pósitrons com fluordesoxiglucose (FDG-PET-CT)
- cintilografia óssea
- aspirado e biópsia de medula óssea
- Hemograma completo
- TFHs
- sódio sérico
- função renal
- testes da função pulmonar
Treatment algorithm
na apresentação inicial: doença limitada
na apresentação inicial: doença extensa
recidiva dentro de 6 meses
recidiva após 6 meses
Contributors
Authors
Bingnan Zhang, MD, MBA
Assistant Professor
Department of Thoracic/Head and Neck Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston
TX
Disclosures
BZ declares that she has no competing interests.
Acknowledgements
Dr Bingnan Zhang would like to gratefully acknowledge Dr Leena Gandhi, Dr Alvin R. Cabrera, Dr Christopher R. Kelsey, Dr Lawrence B. Marks, Dr Rebecca Suk Heist, and Dr Catherine B. Meador, previous contributors to this topic.
Disclosures
LG, ARC, CRK, and LBM declare that they have no competing interests. RSH has received honouraria for consulting from Novartis, Abbvie, Daichii Sankyo, and EMD Serono. RSH's institution (not RSH) has received research funding from Agios, Abbvie, Exelixis, Daichii Sankyo, Novartis, Lilly, Mirati, Corvus, Incyte, and Genentech Roche.
Peer reviewers
Alan Neville, MD
Professor
Assistant Dean
Undergraduate Program
McMaster University
Hamilton
Ontario
Canada
Disclosures
AN declares that he has no competing interests.
References
Key articles
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer [internet publication].Full text
Dingemans AC, Früh M, Ardizzoni A, et al. Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. Jul 2021;32(7):839-53.Full text Abstract
Simone CB 2nd, Bogart JA, Cabrera AR, et al. Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2020 May - Jun;10(3):158-73.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Câncer pulmonar de células não pequenas
- Pneumonia/bronquite
- Tumor carcinoide
More DifferentialsGuidelines
- Suspected cancer: recognition and referral
- NCCN clinical practice guidelines in oncology: small cell lung cancer
More GuidelinesPatient information
Broncoscopia
Câncer de pulmão: perguntas a fazer ao seu médico
Mais Folhetos informativos para os pacientesVideos
Demonstração animada de aspiração pleural
Mais vídeosConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal